Skip to main content
Premium Trial:

Request an Annual Quote

Unfortunately, Their Names Aren't As Catchy As We're Used To

Two new companies offering direct-to-consumer personal genome services have announced their intentions to enter the fray, according to this Houston Chronicle article. DNA sequencing company SeqWright and one of the biggest ancestry DNA companies, Family Tree DNA, are planning to launch products that will analyze DNA for genes associated with disease, similar to services offered by 23andMe and deCODEme, writes Blaine Bettinger of The Genetic Genealogist.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.